Molecular imaging and radionuclide therapy · 2025
18F-FDG PET/CT Parameters and Standard Uptake Values Predicting Contralateral Lung Metastasis in Lung Cancer.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Özdemir Günay Büşra, Üstün Funda
Аннотация
OBJECTIVES: Contralateral lung parenchymal metastasis (CLM), less common than expected in lung cancer, and its exact mechanism is still unknown. To determine the additional value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in determining CLM, its causes, and predictive factors in lung cancer.
METHODS: The data were evaluated by comparing the group with CLM and the group without CLM but with distant metastasis to other organs, two groups known as the M1 classification according to the 9th tumor-node-metastasis classification in lung cancer. Histopathological data, follow-up, and 18F-FDG PET/CT findings, including primary tumor lobe, segment, size, pleural effusion, additional metastasis, and their maximum standardized uptake value (SUVmax) values were recorded, and survival analyses were performed.
RESULTS: CLM developed in 125 cases. Eighty-one individuals had contralateral metastases at diagnosis, and 44 developed CLM during follow-up. Distant metastases were present in 100 patients; there was no CLM in the control group. While there was no statistical difference between the two groups in terms of the SUVmax, mean standardized uptake, and metabolic tumor volume values, the presence of satellite nodules and metastatic nodules in other lobes in the same lung were found to be significantly higher in the CLM group (p=0.007; p<0.001). Also, in the CLM group, ipsilateral nodules had significantly higher SUV values than the control group (3.47 g/mL in the CLM group vs 2.81 g/mL in the control group; p=0.046). Pleural metastasis and effusion were more common in the CLM group (p=0.003; p=0.036). The mean SUV values in pleural metastases and pleural effusions in the CLM group were statistically significantly higher (p=0.048 and p=0.037). In statistical analyses, satellite nodules increase the probability of CLM fourfold, while ipsilateral other lobe nodules in the same lung increase it by 5.527 times (p=0.012; R=-0.2752 and p=0.005; R=-0.3672). Additionally, the absence of necrosis in the initial tumor raises the probability of metastasis to the contralateral lung by 3.326 times during follow-up (p=0.015; R=0.2656).
CONCLUSION: The study emphasized the role of ipsilateral nodules, pleural effusion, and pleural metastasis in predicting CLM using 18F-FDG PET/CT imaging.
METHODS: The data were evaluated by comparing the group with CLM and the group without CLM but with distant metastasis to other organs, two groups known as the M1 classification according to the 9th tumor-node-metastasis classification in lung cancer. Histopathological data, follow-up, and 18F-FDG PET/CT findings, including primary tumor lobe, segment, size, pleural effusion, additional metastasis, and their maximum standardized uptake value (SUVmax) values were recorded, and survival analyses were performed.
RESULTS: CLM developed in 125 cases. Eighty-one individuals had contralateral metastases at diagnosis, and 44 developed CLM during follow-up. Distant metastases were present in 100 patients; there was no CLM in the control group. While there was no statistical difference between the two groups in terms of the SUVmax, mean standardized uptake, and metabolic tumor volume values, the presence of satellite nodules and metastatic nodules in other lobes in the same lung were found to be significantly higher in the CLM group (p=0.007; p<0.001). Also, in the CLM group, ipsilateral nodules had significantly higher SUV values than the control group (3.47 g/mL in the CLM group vs 2.81 g/mL in the control group; p=0.046). Pleural metastasis and effusion were more common in the CLM group (p=0.003; p=0.036). The mean SUV values in pleural metastases and pleural effusions in the CLM group were statistically significantly higher (p=0.048 and p=0.037). In statistical analyses, satellite nodules increase the probability of CLM fourfold, while ipsilateral other lobe nodules in the same lung increase it by 5.527 times (p=0.012; R=-0.2752 and p=0.005; R=-0.3672). Additionally, the absence of necrosis in the initial tumor raises the probability of metastasis to the contralateral lung by 3.326 times during follow-up (p=0.015; R=0.2656).
CONCLUSION: The study emphasized the role of ipsilateral nodules, pleural effusion, and pleural metastasis in predicting CLM using 18F-FDG PET/CT imaging.